Sanorin drops called. 0.05% fl. 10ml # 1 for children

Structure

1 ml contains:

Active ingredient: naphazoline nitrate 0.5 mg

Excipients: boric acid, ethylenediamine, methyl parahydroxybenzoate, water.

pharmachologic effect

Sanorin is a vasoconstrictor.

Excites alpha2-adrenergic receptors.

Pharmacodynamics

It causes narrowing of the vessels of the mucous membranes and reduces swelling, hyperemia, exudation of the mucous membrane of the respiratory tract, facilitates nasal breathing.

With prolonged use, the vasoconstrictor effect gradually decreases, and therefore, after 5-7 days of treatment, you should take a break for several days.

Indications

Acute rhinitis, sinusitis, laryngitis, eustachitis, rhinoscopy, hay rhinitis, rhinitis, allergic rhinitis.

Contraindications

Hypersensitivity, arterial hypertension, an increase in the thyroid gland, tachycardia, severe atherosclerosis, glaucoma, children under 2 years of age (0.1% emulsion, 0.05 and 0.1% solution), up to 15 years (0.1% solution).

Side effects

Irritation of the mucous membrane, reactive hyperemia

with prolonged use - swelling of the mucous membrane

nausea, headache, increased blood pressure, tachycardia (with resorptive action).

Interaction

Simultaneous reception with MAO inhibitors and a period of up to 14 days after the end of their use increases the risk of severe arterial hypertension (release of deposited catecholamines under the action of naphazoline).

Slows down the absorption of local anesthetics.

How to take, course of administration and dosage

For acute rhinitis, sinusitis, eustachitis, laryngitis, to facilitate rhinoscopy for adults and adolescents over 15 years old - 1-3 drops of 0.1% nasal drops in each nasal passage 3-4 times a day.

The course of treatment is short-term, until the symptoms of nasal congestion disappear, but not more than 1 week in adults and 3 days in children.

Re-use of the drug is possible after a few days.

In case of nosebleeds, a cotton swab moistened with 0.05% Sanorin solution can be placed in the nasal passage.

As an additional agent in the treatment of conjunctivitis of bacterial origin, nasal drops 0.05% are instilled into the conjunctival sac, 1-2 drops 3-4 times a day.

Overdose

Symptoms: hypothermia, bradycardia, hyperhidrosis, drowsiness, coma.

Treatment: symptomatic.

Special instructions

With prolonged use, the severity of the vasoconstrictor effect gradually decreases (the phenomenon of tachyphylaxis), and therefore it is recommended after 5-7 days of use in adults and after 3 days of use in children to take a break for several days.

Release form

Nasal drops

Storage conditions

In a dark place at a temperature not exceeding 25 В° C.

Shelf life

4 years

Active substance

Naphazoline

Name ENG

SANORIN

ATX code

Naphazoline

Dosage

0.1% x 10ml

Structure

1 ml contains: Active ingredient: naphazoline nitrate 0.5 mg

Excipients: boric acid, ethylenediamine, methyl parahydroxybenzoate, water.

Indications

acute rhinitis of various etiologies

Otitis media - as an additional agent to reduce swelling of the nasopharyngeal mucosa

Sinusitis

Eustachitis

Laryngitis

В· To reduce swelling of the mucous membranes of the nose, nasopharynx and paranasal sinuses during diagnostic and therapeutic procedures

If necessary to stop nosebleeds.

Contraindications

hypersensitivity to drug components

, В· Chronic rhinitis

, В· Atrophic rhinitis

, В· Angle-closure glaucoma

, В· Severe eye diseases

,В· arterial hypertension

, В· Pronounced atherosclerosis

, В· Tachycardia

, В· Hyperthyroidism

,В· diabetes

, В· Simultaneous administration of monoamine oxidase inhibitors and a period up to 14 days after the end of their use.

, Sanorin 0.05% solution is contraindicated in children under 2 years of age.

, Sanorin 0.1% solution is contraindicated in children under 15 years of age.

,

INN / Active ingredient

naphazoline nitrate

Storage conditions and periods

In a dark place at a temperature of 10-25 degrees.

Expiration date: 4 years

Specifications

Category

Runny nose

Scope of the drug

Ear, Throat, Nose

Release form

Drops

Manufacturer country

Czech

Package quantity, pcs

one

Scope of application

Virology

Minimum age from

2 years old

Way of introduction

Nasally

Vacation conditions

Without recipe

Volume, ml.

10 ml

Brand name

Teva

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Dropper bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Decongestant - alpha adrenergic agonist

Anatomical and therapeutic characteristics

R01AA08 Naphazoline

Dosage form

Nasal drops

The target audience

Children

Dosage (volume) of the substance in the preparation

500 mcg

Expiration date in days

1460

Package weight, g

ten

Mode of application

:

In acute rhinitis, sinusitis, eustachitis, laryngitis, to facilitate rhinoscopy for adults and adolescents over 15 years old - 1-3 drops of 0.1% nasal drops in each nasal passage 3-4 times a day. < br> < br> Course of treatment - short-term, until the symptoms of nasal congestion disappear, but not more than 1 week in adults and 3 days in children.

Re-use of the drug is possible in a few days. < br> < br> In case of nosebleeds, a cotton swab moistened with 0.05% Sanorin solution can be placed in the nasal passage. < br> < br> As an additional agent in the treatment of conjunctivitis of bacterial origin, drops are instilled into the conjunctival sac nasal 0.05% 1-2 drops 3-4 times a day.

Information on technical characteristics, delivery set, country of manufacture